Clinical Laserthermia Systems AB (publ) (CLS-B) — Financial Flexibility Index
Clinical Laserthermia Systems AB (publ) (CLS-B) has a Financial Flexibility Index of -0.97x as of December 2025. Free cash flow of Skr-9.71 Million (operating CF Skr-10.69 Million minus capex Skr982.00K) represents -1% of total liabilities (Skr10.00 Million). Also explore Clinical Laserthermia Systems AB (publ) (CLS-B) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Clinical Laserthermia Systems AB (publ) Financial Flexibility Index (2008–2025)
Historical Financial Flexibility Index trend for Clinical Laserthermia Systems AB (publ) across 18 annual periods. Check Clinical Laserthermia Systems AB (publ) strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Clinical Laserthermia Systems AB (publ) (2008–2025)
Year-by-year free cash flow to debt coverage for Clinical Laserthermia Systems AB (publ). For the full company profile including market capitalisation, see Clinical Laserthermia Systems AB (publ) stock valuation.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.05x | Skr-30.50 Million | Skr-33.20 Million | Skr10.00 Million | ▲ +27.3% |
| 2024 | -4.19x | Skr-53.99 Million | Skr-56.45 Million | Skr12.88 Million | ▲ +2.3% |
| 2023 | -4.29x | Skr-60.96 Million | Skr-66.45 Million | Skr14.20 Million | ▼ -155.0% |
| 2022 | -1.68x | Skr-70.13 Million | Skr-70.69 Million | Skr41.64 Million | ▼ -16.9% |
| 2021 | -1.44x | Skr-65.62 Million | Skr-66.17 Million | Skr45.55 Million | ▲ +20.3% |
| 2020 | -1.81x | Skr-55.06 Million | Skr-55.41 Million | Skr30.47 Million | ▼ -47.6% |
| 2019 | -1.22x | Skr-38.77 Million | Skr-39.12 Million | Skr31.67 Million | ▲ +72.3% |
| 2018 | -4.43x | Skr-36.35 Million | Skr-38.72 Million | Skr8.21 Million | ▼ -168.1% |
| 2017 | -1.65x | Skr-19.71 Million | Skr-24.39 Million | Skr11.94 Million | ▲ +6.5% |
| 2016 | -1.77x | Skr-18.09 Million | Skr-19.63 Million | Skr10.24 Million | ▲ +70.5% |
| 2015 | -5.98x | Skr-16.78 Million | Skr-18.68 Million | Skr2.81 Million | ▼ -141.3% |
| 2014 | -2.48x | Skr-13.33 Million | Skr-15.74 Million | Skr5.38 Million | ▲ +51.4% |
| 2013 | -5.10x | Skr-15.86 Million | Skr-18.30 Million | Skr3.11 Million | ▼ -51.6% |
| 2012 | -3.36x | Skr-9.99 Million | Skr-12.05 Million | Skr2.97 Million | ▼ -75.5% |
| 2011 | -1.92x | Skr-4.17 Million | Skr-5.96 Million | Skr2.17 Million | ▲ +10.6% |
| 2010 | -2.14x | Skr-3.01 Million | Skr-4.92 Million | Skr1.41 Million | ▼ -424.7% |
| 2009 | 0.66x | Skr1.04 Million | Skr-2.28 Million | Skr1.57 Million | ▼ -37.2% |
| 2008 | 1.05x | Skr1.94 Million | Skr-69.30K | Skr1.85 Million | — |